Ipca Laboratories

Quarterly
Consolidated
ParticularsSep '25Dec '25Mar '26Jun '26Sep '26
Revenue2,5842,4132,4822,8132,935
Expenses2,1351,9842,0322,2412,364
EBITDA572.78553.54577.61694.77698.51
EBIT411.19463.60424.65583.96559.74
Profit Before Tax391.58445.98404.45572.08547.17
Net Profit283.50364.05309.40422.81391.54
Financial Ratios
Operating Profit Margin20.13%23.87%22.26%24.92%23.17%
Net Profit Margin12.70%13.08%13.96%14.41%13.49%
Earning Per Share (Diluted)11.1412.8611.7915.8414.79
Dividends Per Share0.000.000.000.000.00